Related Experiment Videos
In vitro PKA phosphorylation-mediated human PDE4A4 activation
France Laliberté1, Susana Liu, Elise Gorseth
1Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutical Research, P.O. Box 1005, Pointe Claire, H9R4P8, Dorval, QC, Canada.
FEBS Letters
|February 20, 2002
Summary
Phosphorylation by PKA enhances PDE4A4 enzyme activity and Mg(2+) sensitivity. This modulation affects drug potency, suggesting cofactor binding affinity regulates phosphodiesterase 4 activity.
Area of Science:
- Biochemistry
- Enzymology
- Molecular Biology
Background:
- Phosphodiesterase 4 (PDE4) enzymes are crucial regulators of cyclic adenosine monophosphate (cAMP) signaling.
- The catalytic activity of PDE4 enzymes relies on a binuclear metal center, typically involving divalent cations like Mg(2+).
Purpose of the Study:
- To investigate the role of magnesium ions (Mg(2+)) in the catalytic activity of PDE4A4.
- To determine the effect of protein kinase A (PKA)-mediated phosphorylation on PDE4A4 activity and its response to Mg(2+).
Main Methods:
- Expression and purification of PDE4A4 in Sf9 insect cells.
- Enzyme kinetics assays measuring cAMP hydrolysis in the presence of varying Mg(2+) concentrations.
- In vitro phosphorylation of PDE4A4 using the PKA catalytic subunit.
Main Results:
- PDE4A4 exhibited a biphasic Mg(2+) dose-response, indicating complex cofactor binding.
- PKA phosphorylation significantly increased PDE4A4's sensitivity to Mg(2+), enhancing cAMP hydrolysis by 4-fold without altering substrate affinity (Km).
- Phosphorylation modulated the potency of specific PDE4 inhibitors, (R)- and (S)-rolipram, but not CDP-840 or SB-207499.
Conclusions:
- Modulating the cofactor (Mg(2+)) binding affinity of PDE4 is a key mechanism for regulating its enzymatic activity.
- PKA-mediated phosphorylation represents a significant regulatory pathway for PDE4A4 function and inhibitor response.